1 / 7

WIPO-UKRAINE SUMMER SCHOOL ON INTELLECTUAL PROPERTY – JULY 2011

WIPO-UKRAINE SUMMER SCHOOL ON INTELLECTUAL PROPERTY – JULY 2011. Selected Cases on Patents and Biotechnology. Programme. The oncomouse Relaxin WARF. Oncomouse. Transgenic mouse susceptible to cancer – by introducing an oncogene Issues Should patents be granted?

kieu
Télécharger la présentation

WIPO-UKRAINE SUMMER SCHOOL ON INTELLECTUAL PROPERTY – JULY 2011

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. WIPO-UKRAINE SUMMER SCHOOL ON INTELLECTUAL PROPERTY – JULY 2011 Selected Cases on Patents and Biotechnology

  2. Programme • The oncomouse • Relaxin • WARF

  3. Oncomouse • Transgenic mouse susceptible to cancer – by introducing an oncogene • Issues • Should patents be granted? • What are moral implications • Consequences of differnet decisions from different offices

  4. Relaxin • Application for gene coding of second unexpected form of human relaxin and for cloned synthetic form • Is invention novel? • Is there an inventive step? • Is patent contrary to morality? • Is this “patenting life”

  5. WARF • Application relating to human stem cells refused on moral grounds and referred to enlarged board of appeal

  6. WARF – 2 • EPO Rules • Rule 23(d) “Under Article 53(a), European patents shall not be granted in respect of biotechnological inventions which, in particular, concern the following: ..........(c) uses of human embryos for industrial or commercial purposes; • Art. 53(a) prevents the grant of patents in respect of inventions the exploitation of which would be contrary to morality.

  7. WARF - 3 • Questions • Does EPC rule 23 apply to applications filed before rule enters into force • If yes does rule forbid products produced by destruction of embryos (latter not part of claims) • If no to above does EPC Rule 53 forbid such patenting • Is fact that after date of filing such products can be obtained without destruction of embryos

More Related